Related Experiment Video
Updated: Aug 30, 2026

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
Published on: August 13, 2015
Epidemiology and demographics of prostatitis
1Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. ajschaeffer@northwestern.edu
Insights
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) significantly impacts men's quality of life, with limited treatment success. Further research is needed to understand its natural history and optimize therapies for this common condition.
Area of Science:
- Urology
- Men's Health
- Pain Management
Background:
- Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a prevalent condition affecting men across all demographics.
- Patients with CP/CPPS often experience a diminished quality of life.
- Current empiric therapies offer minimal benefit to many individuals diagnosed with CP/CPPS.
Purpose of the Study:
- To address the lack of epidemiological data on CP/CPPS.
- To investigate the natural and treated history of CP/CPPS through long-term follow-up.
- To establish prevalence estimates, morbidity rates, and treatment outcomes for CP/CPPS.
Main Methods:
- Long-term cohort follow-up studies.
- Epidemiological investigations to determine prevalence and community-based estimates.
- Analysis of symptom improvement/deterioration and treatment benefits/harms.
Main Results:
- Leukocyte and bacterial counts do not correlate with symptom severity in CP/CPPS patients.
- Current anti-inflammatory and antimicrobial therapies show limited efficacy.
- Non-bacterial and non-leukocyte factors likely contribute to CP/CPPS symptoms.
Conclusions:
- CP/CPPS is a complex condition with multifactorial causes.
- More research is essential to understand the underlying mechanisms and develop effective treatments.
- Reliable outcome measures for CP/CPPS treatment efficacy and safety are urgently needed.
Abstract:
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a multifactorial problem affecting men of all ages and demographics. Currently, there is a relative dearth of epidemiological information on CPPS. It is clear that patients with CPPS have a dismal quality of life and many have benefited only minimally from empiric, goal-directed therapy. Long-term follow-up of the CPPS cohort will answer important questions about the natural and treated history of this syndrome. Similarly, ongoing and future studies will provide community-based and prevalence estimates for CPPS, morbidity rates for men with CPPS, and the rates of symptom improvement and symptom deterioration for these men, as well as the probability of benefits and harm from different treatments. Although men with CP routinely receive anti-inflammatory and antimicrobial therapy, recent studies suggest that leucocyte and bacterial counts do not correlate with severity of symptoms. These findings suggest that factors other than leucocytes and bacteria contribute to the symptoms associated with CPPS. The probability of benefits and harm from different treatments for CPPS, and reliable and valid measures to define these outcomes are eagerly awaited.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Nursing Assessment of the Genitourinary System I: Health History
Microbiota of the Urogenital Tract
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management

